The primary purpose of this study is to determine whether the investigational drug XmAb541 is safe and well tolerated, and to determine an optimal and safe dos…

Ovarian CancerEndometrial CancerGerm Cell Tumor+2 more

~Estimated

~$10 – $8,750

Xencor, Inc.NCT06276491

Phase II Trial of Serum Micro RNA-371 in Detecting Active Germ Cell Tumors in Patients With Suspected Regional Disease - (MAGESTIC Trial: MiRNA in Detecting Active Germ Cell Tumors in Early Suspected and MetastaTIC Disease Trial)

This study evaluates the accuracy of blood-based biomarker testing to predict the presence of active testicular cancer.

Malignant Testicular Germ Cell Tumor

~Estimated

~$10 – $750

University of Southern CaliforniaNCT06060873

Phase 2

A Phase II Multicenter Study of Enfortumab Vedotin With or Without Pembrolizumab in Rare Genitourinary Tumors (E-VIRTUE)

Background: Many cancers of the testicles and urinary tract are rare diseases; these are diseases that affect less than 200,000 people in the United States. I…

Adenocarcinoma of the BladderSquamous Cell Carcinoma of the BladderTesticular Germ Cell Tumors

~Estimated

~$10 – $5,625

National Cancer Institute (NCI)NCT06041503